Can Anyone Take Mounjaro, or Does It Depend on Your Situation?

What does the UK licence actually say about who qualifies?

Mounjaro's UK marketing authorisation covers adults whose BMI sits at 30 or above, as well as adults with a BMI between 27 and 29.9 who also carry at least one weight-related comorbidity. The conditions that count in the 27-plus bracket include type 2 diabetes, high blood pressure, dyslipidaemia (raised cholesterol or triglycerides), obstructive sleep apnoea, and cardiovascular disease, among others. That list is not exhaustive, a prescriber uses clinical judgement about whether a condition is genuinely weight-related and relevant.

For some ethnic backgrounds, UK guidance applies a lower BMI threshold, typically 2.5 kg/m² below the standard figures, reflecting differences in how body composition and cardiometabolic risk present across populations. If you fall into that category, it is worth raising during your consultation rather than assuming you fall short.

BMI is a filter, not a passport. Our prescribers at nume's Mounjaro service (sorry, at our Mounjaro service) review your full medical history, current medicines, and health goals. A number on a calculator does not tell the whole story, which is exactly why a clinical assessment exists. You can also cross-reference your own BMI quickly using the NHS BMI calculator before a consultation.

Who is Mounjaro not suitable for?

The exclusions matter as much as the eligibility criteria, and they deserve a plain answer rather than a footnote.

Tirzepatide is not recommended during pregnancy, while breastfeeding, or if you are actively trying to conceive. The medicine's effects on a developing baby are not sufficiently studied, and an appropriate wash-out period applies before conception is attempted, your prescriber will discuss the specifics. Women using oral contraceptives also need to know that Mounjaro can reduce how well the pill is absorbed: for the first four weeks of treatment, and for four weeks after any dose increase, an additional non-oral method of contraception such as condoms is advisable.

People with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia type 2 (MEN2) should not take tirzepatide. A history of pancreatitis also requires careful prescriber assessment. Severe gastrointestinal conditions, serious eating disorders, and certain kidney or liver problems are further factors a prescriber weighs up. The medicine carries a Black Triangle (▼) symbol in the UK, meaning it is under additional MHRA monitoring as a relatively new treatment. That is a reason to be thorough at the assessment stage, not a reason to avoid it if it is clinically appropriate. You can read about safety concerns around this class of medicine on the MHRA's Yellow Card site, where patients can also report suspected side effects.

Anyone under 18 is outside the licensed age range. Full stop.

Can anyone take tirzepatide if they just want to lose a small amount of weight?

This is one of the most common questions our prescribers encounter, and the honest answer is no. The MHRA's guidance is explicit: GLP-1 and dual-agonist medicines are not assessed or approved for cosmetic or minor weight loss. The licence exists for people whose weight is a medical concern, reflected in the BMI thresholds and comorbidity criteria above.

That framing matters because it shapes what treatment can realistically offer. Mounjaro works alongside a reduced-calorie diet and increased physical activity, it is not a substitute for lifestyle change but a clinical tool that supports it. Some people find the appetite reduction significant; others find it more modest. Results vary, and not everyone loses weight on Mounjaro, a fact worth understanding before starting. For broader context on how weight-loss medicines fit into a wider clinical picture, our weight management overview is a practical starting point.

If you are curious whether your specific situation fits, the right place to answer that is a consultation, not a forum. For detail on the process of actually obtaining a prescription, the question of how to access Mounjaro legally in the UK covers the practical steps. And if you have safety questions beyond eligibility, our page on Mounjaro's serious risk profile addresses what the evidence actually shows.

Does being eligible on paper mean you will be approved?

Not automatically. Meeting the BMI threshold brings you into scope; a clinical review determines whether treatment is appropriate for you specifically. A prescriber checks for drug interactions, reviews any conditions that might be worsened, and considers whether Mounjaro is the right tool given your history. They may also discuss cost alongside clinical suitability, a quick look at what Mounjaro typically costs privately in the UK can help you prepare for that conversation.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the same day you submit it. A real clinician looks at your answers, not software. If treatment is approved as clinically suitable, your prescription is issued and your order dispatched the same day, tracked and delivered free the next working day. If it is not the right fit, you will be told clearly and directed appropriately. That is what a clinical assessment is for. Speak to our prescribers via a free consultation to find out where you stand.